Effect of oral antihistamine on local injection site reactions with self-administered glatiramer acetate.

Author: BoutwellChristine, ConnerJill, DenneyDouglas, Oleen-BurkeyMerriKay, PardoGabriel

Paper Details 
Original Abstract of the Article :
Patients with multiple sclerosis often use injectable medication such as glatiramer acetate or interferons to treat their disease. Subcutaneous injections may be associated with local injection site reactions (LISRs), which can include itching, pain, swelling, or redness. Although not serious, these...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/jnn.0b013e3181c71ab7

データ提供:米国国立医学図書館(NLM)

Oral Antihistamine: A Solution for Glatiramer Acetate Injection Site Reactions?

This study explores the [impact of oral antihistamines on injection site reactions (LISRs)] associated with glatiramer acetate therapy, a journey through the intricate landscape of [multiple sclerosis (MS) treatment]. The research, like a diligent scientist carefully analyzing sand samples, investigates whether [pre-treatment with cetirizine hydrochloride] can reduce the incidence of LISRs in patients receiving glatiramer acetate. The results, however, do not provide conclusive evidence that [cetirizine significantly reduces LISRs] in this context.

Oral Antihistamines: A Potential but Unproven Solution for Glatiramer Acetate LISRs

This study, like a mirage in the desert, suggests that oral antihistamines may not be the definitive solution for reducing LISRs associated with glatiramer acetate. While the findings do not show a significant reduction in LISRs with cetirizine, the study does highlight the need for [further research and exploration of alternative strategies] to alleviate this common side effect of glatiramer acetate therapy.

Managing Glatiramer Acetate LISRs: A Continued Quest

The study highlights the ongoing challenge of [managing LISRs] in patients receiving glatiramer acetate. While this study did not demonstrate a significant benefit from using oral antihistamines, the research underscores the importance of [exploring other potential solutions] and continuing to investigate ways to improve the patient experience with this therapy.

Dr. Camel's Conclusion

This research, like a camel caravan searching for a hidden oasis, explores the potential of oral antihistamines in reducing LISRs associated with glatiramer acetate therapy. The findings do not provide conclusive evidence to support the use of cetirizine for this purpose, indicating the need for continued research and exploration of alternative strategies.
Date :
  1. Date Completed 2010-03-26
  2. Date Revised 2019-10-27
Further Info :

Pubmed ID

20187348

DOI: Digital Object Identifier

10.1097/jnn.0b013e3181c71ab7

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.